These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 9146938)
1. Topical azelastine has a 12-hour duration of action as assessed by histamine challenge-induced exudation of alpha 2-macroglobulin into human nasal airways. Greiff L; Andersson M; Svensson C; Persson CG Clin Exp Allergy; 1997 Apr; 27(4):438-44. PubMed ID: 9146938 [TBL] [Abstract][Full Text] [Related]
2. Onset of action of a topical antihistamine as assessed by histamine challenge-induced plasma exudation responses. Korsgren M; Andersson M; Larsson L; Aldén-Raboisson M; Greiff L Ann Allergy Asthma Immunol; 2006 Feb; 96(2):345-8. PubMed ID: 16498858 [TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy and pharmacokinetic profiles of intranasal and oral cetirizine in a repeated allergen challenge model of allergic rhinitis. Korsgren M; Andersson M; Borgå O; Larsson L; Aldén-Raboisson M; Malmqvist U; Greiff L Ann Allergy Asthma Immunol; 2007 Apr; 98(4):316-21. PubMed ID: 17458426 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis. Corren J; Storms W; Bernstein J; Berger W; Nayak A; Sacks H; Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303 [TBL] [Abstract][Full Text] [Related]
5. Effects of two weeks of topical budesonide treatment on microvascular exudative responsiveness in healthy human nasal airways. Greiff L; Andersson M; Svensson C; Akerlund A; Alkner U; Persson CG Eur Respir J; 1997 Apr; 10(4):841-5. PubMed ID: 9150322 [TBL] [Abstract][Full Text] [Related]
6. Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis. Berger W; Hampel F; Bernstein J; Shah S; Sacks H; Meltzer EO Ann Allergy Asthma Immunol; 2006 Sep; 97(3):375-81. PubMed ID: 17042145 [TBL] [Abstract][Full Text] [Related]
7. Effects of intranasal azelastine on the response to nasal allergen challenge. Saengpanich S; Assanasen P; deTineo M; Haney L; Naclerio RM; Baroody FM Laryngoscope; 2002 Jan; 112(1):47-52. PubMed ID: 11802037 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of intranasally applied dimethindene maleate solution as spray in adult volunteers with symptoms of seasonal allergic rhinitis in the Vienna challenge chamber. Kyrein HJ; Horak F; Nirnberger G; Rehn D Arzneimittelforschung; 1996 Aug; 46(8):794-9. PubMed ID: 9125281 [TBL] [Abstract][Full Text] [Related]
9. Effect of topical nasal azelastine on the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis. Golden S; Teets SJ; Lehman EB; Mauger EA; Chinchilli V; Berlin JM; Kakumanu S; Lucus T; Craig TJ Ann Allergy Asthma Immunol; 2000 Jul; 85(1):53-7. PubMed ID: 10923605 [TBL] [Abstract][Full Text] [Related]
10. Challenge-induced plasma exudation and mucinous secretion in human airways. Greiff L; Andersson M; Coman WB; Lindberg H; Marko-Varga G; Wallwork B; Persson CG Clin Physiol Funct Imaging; 2005 Jul; 25(4):241-5. PubMed ID: 15972027 [TBL] [Abstract][Full Text] [Related]
11. Desloratadine reduces allergen challenge-induced mucinous secretion and plasma exudation in allergic rhinitis. Greiff L; Persson CG; Andersson M Ann Allergy Asthma Immunol; 2002 Oct; 89(4):413-8. PubMed ID: 12392387 [TBL] [Abstract][Full Text] [Related]
12. Histamine skin test reactivity following single and multiple doses of azelastine nasal spray in patients with seasonal allergic rhinitis. Pearlman DS; Grossman J; Meltzer EO Ann Allergy Asthma Immunol; 2003 Sep; 91(3):258-62. PubMed ID: 14533657 [TBL] [Abstract][Full Text] [Related]
13. Histamine and tryptase in nasal lavage fluid after allergen challenge: effect of 1 week of pretreatment with intranasal azelastine or systemic cetirizine. Jacobi HH; Skov PS; Poulsen LK; Malling HJ; Mygind N J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):768-72. PubMed ID: 10329808 [TBL] [Abstract][Full Text] [Related]
14. The effects of the nasal antihistamines olopatadine and azelastine in nasal allergen provocation. Pipkorn P; Costantini C; Reynolds C; Wall M; Drake M; Sanico A; Proud D; Togias A Ann Allergy Asthma Immunol; 2008 Jul; 101(1):82-9. PubMed ID: 18681089 [TBL] [Abstract][Full Text] [Related]
15. Azelastine nasal spray in the management of seasonal allergic rhinitis. Meltzer EO; Weiler JM; Dockhorn RJ; Widlitz MD; Freitag JJ Ann Allergy; 1994 Apr; 72(4):354-9. PubMed ID: 7908778 [TBL] [Abstract][Full Text] [Related]
16. Effect of topical levocabastine on nasal response to allergen challenge and nasal hyperreactivity in perennial rhinitis. de Graaf-in 't Veld T; Garrelds IM; van Toorenenbergen AW; Mulder PG; Gerth van Wijk R; Boegheim JP Ann Allergy Asthma Immunol; 1995 Sep; 75(3):261-6. PubMed ID: 7552929 [TBL] [Abstract][Full Text] [Related]
17. Experimentally induced nasal hypersecretion does not reduce the efficacy of intranasal levocabastine. Borum S; Nielsen K; Bisgaard H; Mygind N Rhinology; 1998 Dec; 36(4):153-5. PubMed ID: 9923056 [TBL] [Abstract][Full Text] [Related]
18. Effects of benzalkonium chloride on innate immunity physiology of the human nasal mucosa in vivo. Storaas T; Andersson M; Persson CG; Steinsvåg SK; Marko-Varga G; Greiff L Laryngoscope; 2000 Sep; 110(9):1543-7. PubMed ID: 10983958 [TBL] [Abstract][Full Text] [Related]
19. Nasal ocular reflexes and eye symptoms in patients with allergic rhinitis. Baroody FM; Foster KA; Markaryan A; deTineo M; Naclerio RM Ann Allergy Asthma Immunol; 2008 Mar; 100(3):194-9. PubMed ID: 18426137 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of azelastine nasal spray in patients with allergic rhinitis compared to placebo and budesonide. Dorow P; Aurich R; Petzold U Arzneimittelforschung; 1993 Aug; 43(8):909-12. PubMed ID: 8105785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]